Efficacy of HCV core antigen detection during the preseroconversion period
- 1 October 2000
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 40 (10) , 1198-1202
- https://doi.org/10.1046/j.1537-2995.2000.40101198.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Risk–Benefit Analysis of Nucleic Acid Testing: The French ExperienceBiologicals, 1999
- Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes.Gut, 1996
- Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)Journal of Immunological Methods, 1996
- Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor StudyTransfusion, 1995
- Improved Detection of Anti‐HCV in Post‐Transfusion Hepatitis by a Third‐Generation ELISAVox Sanguinis, 1995
- Anti‐hepatitis C virus (anti‐HCV) seroconversion in patients undergoing hemodialysis: comparison of second‐ and third‐generation anti‐HCV assaysTransfusion, 1994
- Sequence analysis of the core gene of 14 hepatitis C virus genotypes.Proceedings of the National Academy of Sciences, 1994
- A twelve year natural history of hepatitis C virus infection in hemodialyzed patientsKidney International, 1994